Abstract

Pipazethate HCL toxicity: A Mini Review

Highlights

  • PipazethateHCl is 2-(2-piperidinoethoxy)ethyl 10H-pyrido [3,2-b] [1,4]benzothiadiazine-10-carboxylate hydrochloride [1]

  • Somnolence, agitation, seizures and more frequently coma are the main neurological manifestations in those patients while respiratory symptoms ranges from Kussmaul breathing to respiratory depression and apnea

  • Neurological and respiratory manifestations are usually related to the central depressive effect of the drug and subsequently death is usually related to serious hypoxia [4]

Read more

Summary

Mahmoud Abdelnaby*

Medical Research Institute, University of Alexandria, Egypt, Tel:. Pipazethate HCl is a centrally acting non-narcotic antitussive which is rarely used nowadays in developed countries while it is still widely used in developing countries. Drug toxicity is rarely reported in the literature and it includes wide variety of neurological, respiratory and cardiovascular symptoms. The aim of the work was to highlight the manifestations of the toxicity of this drug and to illustrate how to manage them for a better outcome and survival

Introduction
Management and Prognosis
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.